Background. To further improve the screening, diagnosis, and therapy of patients with
nonsmall cell lung cancer (NSCLC) additional diagnostic tools are urgently needed. Gene …

Purpose To determine whether COX-2 expression is associated with clinicopathological
parameters, including c-erb-B2 overexpression and angiogenesis, and the disease-free …

Objective: Cyclooxygenase-2 (COX-2) has been claimed to play role in carcinogenesis and
be related to a bad prognosis in tumours. The aim of this study was to investigate the …

Epidermal growth factor receptor (EGFR) mutations occur mostly in patients with lung
adenocarcinoma; such patients are also more likely to express cyclooxygenase-2 (COX-2) …

The epidermal growth factor receptor (EGFR) is part of a family of plasma membrane
receptor tyrosine kinases that control many important cellular functions, from growth and …

Evaluation of: Tsubochi H, Nobuyuki S, Hiyama M et al.: Combined analysis of
cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer. Ann. Thorac …

Aim: The aim of this study was to evaluate the association and interaction of genotypic
polymorphisms in the cyclooxygenase 2 (Cox-2) gene with smoking habits with lung cancer …

Purpose: To determine the effect of taxane-based chemotherapy on intratumoral levels of
cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2) in patients with non–small cell …

Lung cancer is the leading cause of cancer death in the USA. Conventional therapy using
chemotherapy, radiation therapy, and a combination of the two, has yielded modest …

Background Multiple relevant risk factors for lung cancer have been reported in different
populations, but results of previous studies were not consistent. Therefore, a meta-analysis …